Many people on semaglutide or tirzepatide struggle to hit even 60-80 grams of protein per day, well below the 1.2-2.0 g/kg/day that research recommends during weight loss
Healthcare professionals must carefully weigh potential benefits against risks, ensure appropriate monitoring, and maintain realistic expectations about outcomes
Human tolerability data comes from Phase I and II clinical investigations in obese adult volunteers
Despite broad preclinical support, human data are extremely limited
Unregulated substances that are not meant for human use, including IGF-1 LR3, can also have unknown or potentially debilitating side effects
Our online pharmacy operates in full compliance with Malaysian pharmaceutical regulations, and all medications are sourced from authorised distributors